Skip to content
  • Migraine
  • Our Science
    • POD Technology
    • Publications & Presentations
    • Meetings
    • Clinical Trials
    • Intellectual Property
  • Contact
  • Migraine
  • Our Science
    • POD Technology
    • Publications & Presentations
    • Meetings
    • Clinical Trials
    • Intellectual Property
  • Contact

Board of Directors

  • Impel History
  • Leadership
  • Board of Directors
  • Scientific Advisors
  • Collaborations

Board of Directors

Tim-Nelson
Timothy S. Nelson

Director

Diane-Wilfong
Diane Wilfong

Director

David-Allison
David Allison, Ph.D.

Westlake Village BioPartners

Director

Ali-Satvat
Ali Satvat

KKR

Director

Darren Cline
Darren Cline

Director

CONNECT WITH US
Icon Twitter link to Twitter Icon LinkedIn link to linkedIn
Impel Pharmaceuticals is a commercial-stage pharmaceutical company developing first-in-class intranasal drug treatments for disorders with high unmet medical needs.

IMPEL, POD, Trudhesa, Trudhesa DIRECT, and the Impel and Trudhesa Logos are trademarks of Impel Pharmaceuticals. Other trademarks are the property of the respective owner(s).

Impel Pharmaceuticals LLC

Privacy Policy

Terms of Service

Social Media Policy

CA Disclosure

© 2025 Impel Pharmaceuticals LLC. All Rights Reserved

Privacy Policy

Terms of Service

Social Media Policy

CA Disclosure